Edition:
United Kingdom

Evotec AG (EVTG.DE)

EVTG.DE on Xetra

14.56EUR
2:42pm BST
Change (% chg)

€-0.45 (-3.00%)
Prev Close
€15.02
Open
€14.80
Day's High
€14.80
Day's Low
€14.27
Volume
714,114
Avg. Vol
1,154,865
52-wk High
€22.50
52-wk Low
€11.28

Select another date:

Wed, Apr 18 2018

BRIEF-Evotec Says Endometriosis Programme With Bayer Moves To Phase I Development

* DGAP-NEWS: EVOTEC AND BAYER ADVANCE THIRD ENDOMETRIOSIS PROGRAMME INTO PHASE I CLINICAL DEVELOPMENT Source text for Eikon: Further company coverage:

BRIEF-Evotec AG Says ‍Plans Conversion Into European Company​

* SAYS ‍PLANS CONVERSION INTO EUROPEAN COMPANY​ Source text for Eikon: Further company coverage: (Reporting by Frankfurt Newsroom)

Sanofi, Evotec team up for research on infectious diseases treatment

PARIS Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.

BRIEF-Evotec, Apeiron Biologics receive milestone payment from Sanofi

* SAYS ‍EVOTEC AND APEIRON ACHIEVE FIRST MILESTONE IN IMMUNO-ONCOLOGY ALLIANCE WITH SANOFI​

Select another date: